A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and ...

The clinical burden of carbapenem-resistant Acinetobacter baumannii has worsened across U.S. hospitals in recent years, according to a study published April 17 in BMC Infectious Diseases.  The ...

The following is a summary of “Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in ...

The antibiotic-resistant ‘superbug' causes severe disease and poses significant challenges to global public health ...

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

A new strain of the superbug Acinetobacter baumannii is proving to not just be antibiotic resistant, but also fully equipped with the tools to spread and develop further resistance to treatments.

A study of U.S. hospital data shows that carbapenem-resistant Acinetobacter baumannii (CRAB) accounted for more than a third of all A baumannii infections from 2018 through 2022 and is increasingly ...

Article continues below Analysing 10 years’ worth of data, scientists discovered that most Acinetobacter baumannii (A. baumannii) infections at the main tertiary hospital in Terengganu ...

Joshua D. Hartzell, MD, Assistant Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland; Infectious Disease Fellow, Department of Internal Medicine ...

Co. Ltd. has identified cyclopeptides reported to be useful for the treatment of Acinetobacter infections, particularly A. baumannii infections.

The conference will feature an oral presentation of the BV100 Phase 2 data in patients with ventilator associated bacterial pneumonia (VABP) suspected or confirmed to be due to carbapenem resistant ...